Sharp HealthCare Selects MEDai’s Pinpoint Review to Prevent Readmissions

ORLANDO, Florida -

- Baldridge Award Winner Builds on Results of Pinpoint Quality(R)/ Pinpoint Compliance(R)

MEDai, Inc., an Elsevier company and leading provider of advanced healthcare solutions including hospital outcomes analysis and award-winning predictive analytics, has announced that Sharp HealthCare, a 1,700-bed, seven-facility system serving the San Diego area, has selected the company’s Pinpoint Review(TM) product. The solution is designed to alert providers to patients at risk for developing hospital acquired conditions or at risk for readmission.

Sharp will use Pinpoint Review to support quality improvement and The Sharp Experience, a sweeping performance improvement initiative launched in 2001. Pinpoint Review will provide Sharp with near-time triggers for core measures, hospital/system-wide surveillance of safety risks, physician performance reporting and forecasts of readmissions.

“Sharp’s selection of Pinpoint Review is based on our personal experience with the prebuilt measures of clinical performance and ease of use found within two other MEDai tools, Pinpoint Quality and Pinpoint Compliance,” said Nancy G. Pratt, RN, MS, Sharp’s Senior Vice-President of Clinical Effectiveness. “Collectively, these tools offer Sharp near-time access to clinical data for performance improvement, while Pinpoint Review, in particular, addresses readmissions and new and emerging clinical measures of care.”

For the past nine years, Sharp has relied on MEDai’s Pinpoint Quality to reduce urinary tract infection rates, reduce blood utilization, and monitor quality outcomes across diseases. MEDai’s solutions also assisted Sharp in being recognized with the coveted Malcolm Baldridge National Quality Award in 2007.

“MEDai is pleased that Sharp has selected Pinpoint Review to focus on the likelihood of its patients developing complications or requiring readmission,” said Swati Abbott, President of MEDai. “Sharp is taking an important step in preventing situations that can increase mortality rates, boost healthcare costs, compromise patient care quality and safety, and result in lower reimbursement.”

Pinpoint Review is the latest addition to a suite of MEDai-developed tools, which includes Pinpoint Quality and Pinpoint Compliance. Pinpoint Quality’s retrospective analysis helps hospitals and physicians identify areas for improvement, facilitating improved performance, outcomes, patient satisfaction, efficiency and cost savings. Pinpoint Compliance provides a time-saving, Web-based solution for organizations to collect, report and submit data to the Joint Commission and other regulatory agencies, allowing hospitals to participate in accreditation, quality improvement and compliance initiatives. Pinpoint Review adds real-time decision support, including the application of alerts and predictive models to patient data while patients are still in the hospital.

About Sharp HealthCare

Sharp HealthCare, a not-for-profit integrated regional health care delivery system based in San Diego, includes four acute-care hospitals, three specialty hospitals and two medical groups: Sharp Rees-Stealy and Sharp Community Medical Group. Sharp was named a recipient of the 2007 Malcolm Baldrige National Quality Award ( www.sharp.com/en/choose-sharp/baldrige/index.cfm) and was the first health care system to be named a gold-level award recipient by the California Council for Excellence (CCE) for the California Awards for Performance Excellence (CAPE) program, the state-level affiliate of the Baldrige Award, in 2006.

About MEDai

MEDai, Inc. is a leading health information company offering award- winning solutions for improvement of healthcare delivery. Utilizing cutting- edge technology, payors and care management organizations are able to predict patients at risk, identify cost drivers for their high-risk population, forecast future health plan costs, evaluate patient patterns over time and improve outcomes. For more information on MEDai, visit www.medai.com. Its parent company, Elsevier is a world-leading publisher of scientific, technical and medical information products and services with more than 7,000 employees in over 70 offices across 24 countries.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (www.thelancet.com) and Cell (www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com), Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and Nursing Consult (www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (www.scival.com) and MEDai’s Pinpoint Review (www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media Contact: Christopher Capot KNB Communications +1-212-505-2441 +1-203-379-8019 (mobile) ccapot@knbpr.com

Source: MEDai

Media Contact: Christopher Capot, KNB Communications, +1-212-505-2441, +1-203-379-8019 (mobile), ccapot at knbpr.com .